These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1676526)

  • 1. Effects of MK-801, a non-competitive NMDA antagonist, on linguopharyngeal events in rats.
    Marco LA; Joshi RS; Chronister RB
    Psychopharmacology (Berl); 1991; 103(4):462-6. PubMed ID: 1676526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of clozapine on ketamine-induced linguopharyngeal events in rats.
    Marco LA; Joshi RS; Brigham TE; Aldes LD; Chronister RB
    Eur J Pharmacol; 1989 May; 164(1):171-3. PubMed ID: 2753078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cholinergic and anticholinergic drugs on ketamine-induced linguopharyngeal motor activity.
    Marco LA; Joshi RS; Brown C; Aldes LD; Chronister RB
    Psychopharmacology (Berl); 1988; 96(4):484-6. PubMed ID: 3149770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
    Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD
    Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice.
    Irifune M; Shimizu T; Nomoto M; Fukuda T
    Pharmacol Biochem Behav; 1995; 51(2-3):291-6. PubMed ID: 7667342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional alterations in brain amino acids after administration of the N-methyl-D-aspartate receptor antagonists MK-801 and CGP 39551 in rats.
    Löscher W; Hönack D; Fassbender CP
    Neurosci Lett; 1991 Mar; 124(1):115-8. PubMed ID: 1677457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopharmacological effects of MK-801 in infant and preweanling rat pups.
    Rajachandran L; Goodwin GA; Spear LP
    Pharmacol Biochem Behav; 1991 Oct; 40(2):291-5. PubMed ID: 1805233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic administration of MK-801 protects against N-methyl-D-aspartate- and quisqualate-mediated neurotoxicity in perinatal rats.
    McDonald JW; Silverstein FS; Cardona D; Hudson C; Chen R; Johnston MV
    Neuroscience; 1990; 36(3):589-99. PubMed ID: 2234402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dose-response analysis of the behavioral effects of (+)MK-801 in guinea pig: comparison with CPP.
    Jerram AH; Smith PF; Darlington CL
    Pharmacol Biochem Behav; 1996 Apr; 53(4):799-807. PubMed ID: 8801581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectral analysis of the electroencephalogram in neonatal rats chronically treated with the NMDA antagonist MK-801.
    Gorter JA; Veerman M; Mirmiran M; Bos NP; Corner MA
    Brain Res Dev Brain Res; 1991 Dec; 64(1-2):37-41. PubMed ID: 1786646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranigral but not intrastriatal microinjection of the NMDA antagonist MK-801 induces contralateral circling in the 6-OHDA rat model.
    St-Pierre JA; Bédard PJ
    Brain Res; 1994 Oct; 660(2):255-60. PubMed ID: 7820694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitive and non-competitive NMDA receptor antagonists in spatial learning tasks.
    Bischoff C; Tiedtke PI
    Eur J Pharmacol; 1992 Mar; 213(2):269-73. PubMed ID: 1355738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural motor effects of MK-801 and DNQX parenteral administration in adult cats: dose-response analysis. Modulatory role of dopaminergic D1 and D2 antagonists on MK-801 induced motor behaviours.
    Motles E; Infante C; Gonzalez M
    Arch Ital Biol; 2000 Apr; 138(2):167-74. PubMed ID: 10782256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance to competitive NMDA antagonists, but no crosstolerance with barbiturates.
    Rabbani M; Wright EJ; Little HJ
    Pharmacol Biochem Behav; 1995 Jan; 50(1):9-15. PubMed ID: 7700959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMDA receptor antagonists impair motor performance in immature rats.
    Mikulecká A; Mares P
    Psychopharmacology (Berl); 2002 Aug; 162(4):364-72. PubMed ID: 12172689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The competitive NMDA antagonists CGP 43487 and APV potentiate dopaminergic function.
    Dall'Olio R; Rimondini R; Gandolfi O
    Psychopharmacology (Berl); 1995 Apr; 118(3):310-5. PubMed ID: 7617824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metoclopramide fails to suppress linguopharyngeal events in a rat dyskinesia model.
    Marco LA; Reed TF; Joshi RS; Aldes LD; Chronister RB
    J Neuropsychiatry Clin Neurosci; 1989; 1(1):53-6. PubMed ID: 2535430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra.
    Wedzony K; Czyrak A; Maćkowiak M; Fijał K
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):517-27. PubMed ID: 8740145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of NMDA receptor antagonists on D1, D2 and D1/D2 mediated behaviors in intact rats.
    Dall'Olio R; Rimondini R; Gandolfi O
    Psychopharmacology (Berl); 1996 Jan; 123(2):187-90. PubMed ID: 8741942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the mesolimbic dopamine system by glutamate: role of NMDA receptors.
    Kretschmer BD
    J Neurochem; 1999 Aug; 73(2):839-48. PubMed ID: 10428083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.